ONC vs PTGX
BeOne Medicines AG · Protagonist Therapeutics, Inc.
Relative return (rebased to 100)
Key stats
| Metric | ONC | PTGX |
|---|---|---|
| Price | $368.08 | $145.07 |
| Market Cap | $544.07B | $9.39B |
| P/E | 1896.15 | — |
| P/B | 105.15 | 11.15 |
| P/S | 101.83 | 204.00 |
| ROE | 5.5% | -15.5% |
| Net Margin | 5.4% | -282.8% |
| Gross Margin | 87.5% | — |
| Revenue Growth | 40.2% | -89.4% |
| Dividend Yield | — | — |
| EPS | $0.19 | -$2.01 |
Metrics from owned fundamentals, updated daily. Highlighted values are the more favorable of the two.